Aristides Capital LLC Invests $528,000 in Nebius Group N.V. $NBIS

Key Points

• Aristides Capital LLC purchased 25,000 shares of Nebius Group N.V., valued at approximately $528,000, as part of its new stake in the company during the first quarter.
• Nebius Group's stock recently traded at $70.02, with a market cap of $16.51 billion, and analysts are predicting a consensus target price of $70.80.
• The company reported a loss of ($0.44) earnings per share for the last quarter, missing the consensus estimate, and had a revenue of $47.60 million against an expectation of $95.60 million.

Aristides Capital LLC acquired a new position in Nebius Group N.V. (NASDAQ:NBIS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 25,000 shares of the company's stock, valued at approximately $528,000.

A number of other hedge funds also recently modified their holdings of the stock. IFP Advisors Inc bought a new position in Nebius Group during the first quarter valued at $25,000. Banque Cantonale Vaudoise purchased a new stake in shares of Nebius Group during the first quarter worth $33,000. First Horizon Advisors Inc. purchased a new stake in Nebius Group during the 1st quarter worth about $33,000. Manchester Capital Management LLC bought a new position in Nebius Group in the 1st quarter worth about $34,000. Finally, Whipplewood Advisors LLC bought a new position in Nebius Group in the 1st quarter worth about $36,000. Institutional investors own 21.90% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Northland Securities set a $47.00 price target on shares of Nebius Group and gave the stock an "outperform" rating in a report on Wednesday, May 21st. The Goldman Sachs Group assumed coverage on shares of Nebius Group in a report on Monday, July 14th. They issued a "buy" rating and a $68.00 price target for the company. Wall Street Zen upgraded Nebius Group from a "sell" rating to a "hold" rating in a research report on Monday. Arete assumed coverage on Nebius Group in a report on Thursday, June 5th. They set a "buy" rating and a $84.00 price objective for the company. Finally, Arete Research raised Nebius Group to a "strong-buy" rating in a research note on Thursday, June 5th. Two analysts have rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $70.80.

Nebius Group Trading Up 2.8%

NBIS stock traded up $1.94 during trading on Thursday, reaching $72.04. The company had a trading volume of 8,869,189 shares, compared to its average volume of 13,934,595. The company has a market cap of $16.98 billion, a P/E ratio of 78.76 and a beta of 3.36. The business has a 50 day moving average of $57.03 and a 200 day moving average of $40.74. Nebius Group N.V. has a 52 week low of $14.09 and a 52 week high of $75.96. The company has a debt-to-equity ratio of 0.31, a current ratio of 14.70 and a quick ratio of 14.70.

Nebius Group (NASDAQ:NBIS - Get Free Report) last announced its quarterly earnings data on Tuesday, September 2nd. The company reported ($0.44) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.03). The business had revenue of $47.60 million during the quarter, compared to analyst estimates of $95.60 million. As a group, sell-side analysts forecast that Nebius Group N.V. will post -1.1 earnings per share for the current fiscal year.

About Nebius Group

Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability.